These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12753751)

  • 1. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
    Ikegami K; Tagawa K; Kobayashi M; Osawa T
    Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the correlation between in vivo and in vitro release. Effect of the force of contraction and food on drug release.
    Aoki S; Ando H; Ishii M; Ida K; Watanabe S; Ozawa H
    Biol Pharm Bull; 1994 Feb; 17(2):291-5. PubMed ID: 8205129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
    Katori N; Aoyagi N; Terao T
    Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
    Ikegami K; Tagawa K; Osawa T
    J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC).
    Ishibashi T; Ikegami K; Kubo H; Kobayashi M; Mizobe M; Yoshino H
    J Control Release; 1999 Jun; 59(3):361-76. PubMed ID: 10332066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.
    Shameem M; Katori N; Aoyagi N; Kojima S
    Pharm Res; 1995 Jul; 12(7):1049-54. PubMed ID: 7494801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
    Chung BH; Shim CK
    J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlations.
    Liu Y; Schwartz JB; Schnaare RL; Sugita ET
    Pharm Dev Technol; 2003; 8(4):409-17. PubMed ID: 14601965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
    Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
    Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations.
    Karasulu E; Apaydin S; Ince I; Tuglular I
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):291-8. PubMed ID: 17315541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.